Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study
Siamak Daneshmand(Unknown), Michael A. O’Donnell(University of Iowa Health Care), Tracy M. Downs(University of Wisconsin–Madison), Joel DeCastro(Columbia University Irving Medical Center), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Yair Lotan(Southwestern Medical Center), Kamal S. Pohar(The Ohio State University), Gary D. Steinberg(Rush University Medical Center), William C. Huang(NYU Langone Health), Badrinath R. Konety(Allina Health), Michael Woods(University of Cambridge), Sanjay Patel(Oklahoma City University), Trinity J. Bivalacqua(University of Pennsylvania), Jeffrey A. Jones(Cleveland Clinic), Mark Schoenberg(Montefiore Medical Center), J. Stephen Jones(Cleveland Clinic), Edouard J. Trabulsi(Thomas Jefferson University), Matthew J. Resnick(Vanderbilt University Medical Center)
Cited by 109
Related Papers
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
|Nature|2021|603